Those studies highlighted advances in precision oncology, early cancer detection, artificial intelligence (AI), and personalized cancer care. The meeting was held May 29–June 2 at the McCormick Place Convention Center in Chicago. Featured research included biomarker-driven treatments for bladder and lung cancers, new approaches for triple-negative breast cancer, multicancer early detection testing, and AI-enabled analysis of the tumor microenvironment in colon cancer. Highlights included educational, poster, oral, and case-based sessions.

—Please visit https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-presents-oncology-breakthroughs-spanning-data-science-early-detection-targeted-therapies-at-asco-2026/ to read more.